A phase 1b/2 study of the efficacy and safety of combination hydroxyurea and dose-escalated erythropoietin for treatment of anemia in sickle cell disease (ACHiEvE-SCD). (apre una nuova finestra)

Adeyemo TA, Kiriza N, Oluwole FT, Jelinek M, Jonassaint J, Oluwole O, Saber C, Philips BJ, Akinsanya OJD, Osunkalu VO, DeCastro LM, Novelli EM, Xu JZ

Fonte‎: Blood 2024;144(Suppl 1):178-9.

Indicizzato‎: DOI

DOI‎: 10.1182/blood-2024-205261

https://ashpublications.org/blood/article/144/Supplement%201/178/530726/A-Phase-1b-2-Study-of-the-Efficacy-and-Safety-of (apre una nuova finestra)

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (apre una nuova finestra)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Fonte‎: Eur J Haematol 1996;56(5):326-8.

Indicizzato‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (apre una nuova finestra)

On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. (apre una nuova finestra)

el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.

Fonte‎: Acta Haematol 1995;94(3):128-34.

Indicizzato‎: PubMed 7502628

https://www.ncbi.nlm.nih.gov/pubmed/7502628 (apre una nuova finestra)

Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. (apre una nuova finestra)

Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT.

Fonte‎: Haematologica 2006;91(8):1076-83.

Indicizzato‎: PubMed 16885048

https://www.ncbi.nlm.nih.gov/pubmed/16885048 (apre una nuova finestra)

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease. (apre una nuova finestra)

Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng-Ntim E.

Fonte‎: J Obstet Gynaecol 2007;27(1):82-3.

Indicizzato‎: PubMed 17365469

DOI‎: 10.1080/01443610601062739

https://www.ncbi.nlm.nih.gov/pubmed/17365469 (apre una nuova finestra)

The use of barbiturate coma as salvage therapy in a postoperative Jehovah's Witness patient with life-threatening anemia. (apre una nuova finestra)

Wang SW, Badami CD, Deitch EA.

Fonte‎: Am Surg 2009;75(12):1175-8.

Indicizzato‎: PubMed 19999907

https://www.ncbi.nlm.nih.gov/pubmed/19999907 (apre una nuova finestra)